The article from MedCity News argues that the next evolution in ADHD therapy should move beyond measuring drug efficacy in isolation. Instead, treatment needs to be designed around the full active day of patients, families, and caregivers, who often juggle demanding schedules that extend well past school or work hours.
This shift in focus acknowledges that a medication's effectiveness is only meaningful if it fits into real life. The author suggests that coverage should be continuous enough to support the entire span of daily activities, reducing gaps that can disrupt focus, behavior, and routine management.
No other sources were provided, so the piece stands alone. Its core claim is that aligning ADHD treatment with the practical rhythms of daily life is a necessary next step, even if the article does not specify particular drugs, dosing strategies, or clinical data to support the argument.